Pharma
North Carolina’s Research Triangle sees big investments despite NIH cuts
Johnson & Johnson, Amgen, and Fujifilm Biotechnologies have all recently invested in the RTP.
Biotech
Stay updated on Biotech trends and industry impact. Healthcare Brew provides the latest news and professional analysis on Biotech's role in Biotech & Emerging Modalities and Pharma.
Pharma
What 23andMe’s Regeneron sale means for the industry
This completes the company’s yearslong fall from its $6 billion peak.
Pharma
3 major biotechs make acquisitions
J&J, Eli Lilly, and GSK all made deals on Monday morning.
Pharma
How one biotech CFO prioritizes and learns from her people
Dynavax’s CFO Kelly MacDonald on learning from unexpected sources and asking the right questions.
Pharma
Biotech may not be able to fend off M&A in the coming months, experts say
Biotech has worked hard to fend off M&A. In the wake of a bank collapse and a tightening lending market, that could be coming to an end.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
